The glucose–potassium ratio (GPR) has emerged as a potential biomarker in recent years, and its alterations are associated with various pathological processes, particularly acute brain injury, metabolic disorders, and inflammatory responses8–10. Here, ALDH18A1 is linked to Other metabolic disease.